(Q40390462)

20 September 2017

title

Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease (English)

1 reference

20 September 2017

1 reference

5

Lyne Lalonde

1 reference

20 September 2017

2

Lucie Blais

1 reference

20 September 2017

7

Johanne Collin

1 reference

20 September 2017

Sylvie Perreault

1

1 reference

20 September 2017

Alice Dragomir

series ordinal

3

1 reference

20 September 2017

Marie-Hèlène Bouchard

series ordinal

4

1 reference

20 September 2017

Claudine Laurier

series ordinal

6

1 reference

20 September 2017

language of work or name

1 reference

19 October 2005

1 reference

European Journal of Clinical Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

61

1 reference

20 September 2017

issue

9

1 reference

20 September 2017

page(s)

667-674

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-005-0980-z

20 September 2017

exact match

0 references

cites work

Apparent discontinuation rates in patients prescribed lipid-lowering drugs.

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

1 reference

12 December 2020

High persistence of statin use in a Danish population: compliance study 1993-1998.

1 reference

12 December 2020

Recall accuracy for prescription medications: self-report compared with database information

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?

1 reference

12 December 2020

A comparison of pregnancy history recall and medical records. Implications for retrospective studies

1 reference

12 December 2020

Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research

1 reference

12 December 2020

Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease

1 reference

12 December 2020

Reliability of recall of drug usage and other health-related information

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Comparison of questionnaire information and pharmacy data on drug use.

1 reference

12 December 2020

Interventions to enhance patient adherence to medication prescriptions: scientific review.

1 reference

12 December 2020

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

1 reference

12 December 2020

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec

1 reference

12 December 2020

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

12 December 2020

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

12 December 2020

Risk for myopathy with statin therapy in high-risk patients.

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors

1 reference

12 December 2020

10.1007/S00228-005-0980-Z

Identifiers

DOI

1 reference

20 September 2017

1 reference